Circio and Neoregen Biotech enter collaboration for delivery of novel circular RNA therapeutics using NICT technology
Circio and Neoregen Biotech today announce the start of a research collaboration on novel circular RNA (circRNA) therapeutics based on Circio´s proprietary circVec technology. The parties will test the ability of Neoregen´s NICT (Neoregen Intra-Cellular delivery Technology) delivery system to enhance cellular uptake and nuclear transfer of circVec vectors compared to commercially available delivery technologies. circRNA is an emerging class of novel RNA-therapeutics that offers improved durability and enhanced protein expression compared to mRNA. Due to these potentially significant